Literature DB >> 1765098

Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides.

B Agerberth1, J Y Lee, T Bergman, M Carlquist, H G Boman, V Mutt, H Jörnvall.   

Abstract

We recently isolated from pig intestine and characterized a 31-residue antibacterial peptide named cecropin-P1 with activity against Escherichia coli and several other Gram-negative bacteria. The isolation involved a number of batch-wise steps followed by several chromatography steps. The continued investigation of these antibacterial peptides has now yielded another antibacterial peptide with high activity against both E. coli and Bacillus megaterium. Amino acid analysis showed a very high content of proline (49 mol%) and arginine (26 mol%), an intermediate level of phenylalanine and low levels of leucine, tyrosine, isoleucine, and glycine. The primary structure was determined by a combination of Edman degradation, plasma desorption mass spectrometry and C-terminal sequence analysis by carboxypeptidase Y degradation using capillary zone electrophoresis for detection of liberated residues. The calculated molecular mass was 4719.7 Da, which is in excellent agreement with 4719 Da obtained by plasma desorption mass spectrometry. The peptide was named PR-39 (proline-arginine-rich with a size of 39 residues). The lethal concentration of the peptide was determined against six Gram-negative and four Gram-positive strains of bacteria.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1765098     DOI: 10.1111/j.1432-1033.1991.tb16442.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  63 in total

1.  Structure-function relationships in novel peptide dodecamerswith broad-spectrum bactericidal and endotoxin-neutralizing activities.

Authors:  K H Mayo; J Haseman; H C Young; J W Mayo
Journal:  Biochem J       Date:  2000-08-01       Impact factor: 3.857

2.  Inhibition of ubiquitin-proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide.

Authors:  Y Gao; S Lecker; M J Post; A J Hietaranta; J Li; R Volk; M Li; K Sato; A K Saluja; M L Steer; A L Goldberg; M Simons
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 3.  Mammalian antibiotic peptides.

Authors:  P Síma; I Trebichavský; K Sigler
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

Review 4.  Endogenous production of antimicrobial peptides in innate immunity and human disease.

Authors:  Richard L Gallo; Victor Nizet
Journal:  Curr Allergy Asthma Rep       Date:  2003-09       Impact factor: 4.806

5.  Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity.

Authors:  D A Steinberg; M A Hurst; C A Fujii; A H Kung; J F Ho; F C Cheng; D J Loury; J C Fiddes
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

6.  PR-39, a proline-rich antibacterial peptide that inhibits phagocyte NADPH oxidase activity by binding to Src homology 3 domains of p47 phox.

Authors:  J Shi; C R Ross; T L Leto; F Blecha
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

7.  Cathelicidins Inhibit Escherichia coli-Induced TLR2 and TLR4 Activation in a Viability-Dependent Manner.

Authors:  Maarten Coorens; Viktoria A F Schneider; A Marit de Groot; Albert van Dijk; Marjolein Meijerink; Jerry M Wells; Maaike R Scheenstra; Edwin J A Veldhuizen; Henk P Haagsman
Journal:  J Immunol       Date:  2017-07-14       Impact factor: 5.422

Review 8.  Studies on anticancer activities of antimicrobial peptides.

Authors:  David W Hoskin; Ayyalusamy Ramamoorthy
Journal:  Biochim Biophys Acta       Date:  2007-11-22

9.  Antimicrobial peptides and induced membrane curvature: geometry, coordination chemistry, and molecular engineering.

Authors:  Nathan W Schmidt; Gerard C L Wong
Journal:  Curr Opin Solid State Mater Sci       Date:  2013-08       Impact factor: 11.354

10.  Molecular basis for proline- and arginine-rich peptide inhibition of proteasome.

Authors:  Asokan Anbanandam; Diana C Albarado; Daniela C Tirziu; Michael Simons; Sudha Veeraraghavan
Journal:  J Mol Biol       Date:  2008-09-16       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.